Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesElevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure
Circulation, 07/02/09
Frasure-Smith N et al. – Elevated depression symptoms are related to cardiovascular mortality even after adjustment for other prognostic indicators in pts with comorbid atrial fibrillation (AF) and congestive heart failure (CHF) who receive optimized treatment. Unmarried pts are also at increased risk. Mechanisms and treatment options deserve additional study.
Methods- Substudy of the AF-CHF Trial of rate- versus rhythm-control strategies
- Investigation of whether depression predicts long-term cardiovascular mortality in pts with left ventricular ejection fraction ≤35%, CHF symptoms, and AF history who receive optimal medical care
- Assessment of depression symptoms (Beck Depression Inventory-II) in 974 pts (833 men)
- Cox proportional hazards models adjustments for prognostic factors: age, marital status, CHF cause, creatinine level, left ventricular ejection fraction, paroxysmal AF, previous AF hospitalization, previous electrical conversion, and baseline medications)
- On adjustment elevated depression scores significantly predicted cardiovascular mortality (primary outcome), arrhythmic death, and all-cause mortality
- Elevated depression symptom scores (Beck Depression Inventory-II ≥14) in 32.0% of pts
- Mean follow-up of 39 mo: 246 cardiovascular deaths (111 presumed arrhythmic; 302 all-cause deaths)
- Risks associated with depression and marital status were additive; highest risk in depressed unmarried pts
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Article Search
Sponsor